Patent Ductus Arteriosus Clinical Trials: Lessons Learned and Future Directions
Open Access
- 15 January 2021
- Vol. 8 (1), 47
- https://doi.org/10.3390/children8010047
Abstract
The identification of an optimal management strategy for the patent ductus arteriosus (PDA) in the context of extreme prematurity remains elusive. Observational studies have reported a persistent association between PDA and neonatal adverse outcomes, but by and large, no clinical trial, to date, has demonstrated that treating a PDA results in a reduction of those morbidities. This discrepancy has led many to assume that the PDA is an innocent bystander in the physiological mechanisms responsible for such complications and a reluctance to actively pursue shunt elimination. It would be remiss to discount the volume of evidence available clearly documenting a strong association between longstanding PDA exposure and negative outcomes. There needs to be a radical change in the design, patient selection and possible outcome assessment in any further trials addressing the PDA. The purpose of this review is to explore the reasons that preclude existing clinical trials from definitively ascribing a causal relationship between PDA patency and adverse outcomes in the context of extreme prematurity, why previous studies have failed to demonstrate significant beneficial effects following PDA treatment and how future research may be conducted to allow us to draw concrete conclusions regarding the potential merits of ductal closure.Keywords
This publication has 19 references indexed in Scilit:
- Patent ductus arteriosus is associated with acute kidney injury in the preterm infantPediatric Nephrology, 2019
- Changes in the Diagnosis and Management of Patent Ductus Arteriosus from 2006 to 2015 in United States Neonatal Intensive Care UnitsThe Journal of Pediatrics, 2017
- Morbidities associated with patent ductus arteriosus in preterm infants. Nationwide cohort studyThe Journal of Maternal-Fetal & Neonatal Medicine, 2017
- Mandatory Closure Versus Nonintervention for Patent Ductus Arteriosus in Very Preterm InfantsThe Journal of Pediatrics, 2016
- Trends and Outcomes of Patent Ductus Arteriosus Treatment in Very Preterm Infants in CanadaAmerican Journal of Perinatology, 2016
- A Patent Ductus Arteriosus Severity Score Predicts Chronic Lung Disease or Death before DischargeThe Journal of Pediatrics, 2015
- The definition of a haemodynamic significant duct in randomized controlled trials: a systematic literature reviewActa Paediatrica, 2011
- Towards rational management of the patent ductus arteriosus: the need for disease stagingArchives of Disease in Childhood: Fetal & Neonatal, 2007
- The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trialsSeminars in Neonatology, 2001
- Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants.Archives of Disease in Childhood: Fetal & Neonatal, 1996